Table 3 Clinical outcomes of patients receiving hyperacute stroke treatment
Treatment group | ||||
|---|---|---|---|---|
Outcomes | IVT | MT | IVT + MT | Overall |
Clinical assessment on arrival | ||||
NIHSS (Median) | 10 (6–14) | 16.5 (5.3–21.3) | 18 (11–21) | 11 (6.5–18.0) |
NIHSS (Mean) | 10.4 ± 5.8 | 14.3 ± 8.0 | 16.8 ± 5.4 | 12.2 ± 6.5 |
mRS (Median) | 0 | 0 | 0 | 0 |
mRS (Mean) | 0.3 ± 0.8 | 0.1 ± 0.3 | 0.5 ± 1.2 | 0.3 ± 0.9 |
Clinical assessment on discharge | ||||
NIHSS (Median) | 4 (1–8) | 17.5 (3.8–19.8) | 9 (2–20) | 4.5 (2.0–12.8) |
NIHSS (Mean) | 5.5 ± 5.9 | 14.3 ± 9.4 | 10.7 ± 7.8 | 7.5 ± 7.3 |
mRS (Median) | 3 (1–4) | 5 (3–6) | 5 (3–6) | 4 (1–5) |
mRS (Mean) | 2.8 ± 1.7 | 4.3 ± 1.8 | 4.3 ± 1.7 | 3.3 ± 1.9 |
Clinical assessment at 3 months | ||||
NIHSS (Median) | 1 (0–3) | 5.5 (0.0–12.8) | 6.5 (3.0–12.3) | 2.0 (0.0–5.3) |
NIHSS (Mean) | 2.3 ± 4.1 | 6.3 ± 6.2 | 7.6 ± 6.4 | 3.6 ± 5.1 |
mRS (Median) | 1 (0–4) | 5 (1–6) | 5.5 (3–6) | 2 (1–6) |
mRS (Mean) | 2.0 ± 2.2 | 3.8 ± 2.4 | 4.5 ± 1.8 | 2.8 ± 2.4 |
ENR | 25 (52.1) | 1 (9.1) | 4 (25.0) | 30 (40.0) |
ENS | 17 (35.4) | 4 (36.4) | 4 (25.0) | 25 (33.3) |
END | 6 (12.5) | 6 (54.5) | 8 (50.0) | 20 (26.7) |
Length of stay (days) | 8.8 ± 7.52 | 9.1 ± 4.91 | 13.0 ± 9.20 | 9.8 ± 7.69 |